Sol-Gel Technologies Ltd.
NASDAQ:SLGLBiotechnology
+$1.19 today
- Market cap
- $174.70M
- Beta
- 1.13
- P/E (TTM)
- -194.1
- EPS (TTM)
- -$0.37
Volume 0.03M
Average 0.04M
SLGL Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Sol-Gel Technologies Ltd.NASDAQ: SLGL
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 40.0% from a year ago
Cash & equivalents stood at $10.14M at the end of Q1 FY2026, down 40.0% from a year earlier and down 8.1% from the prior quarter. Over 3 fiscal years it compounded at -3.9% a year.
Context
- Cash & equivalents amounted to 17.3% of total assets at the end of Q1 FY2026, down 45.1 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -40.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 11.03M USD
- Year-over-year change
- -43.4%
- 4-year CAGR
- -13.9%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 11.03M | -43.4% |
| FY2024 | 2024-12-31 | 19.49M | +159.4% |
| FY2023 | 2023-12-31 | 7.51M | -39.6% |
| FY2022 | 2022-12-31 | 12.45M | -38.0% |
| FY2021 | 2021-12-31 | 20.09M | — |
Cash & Equivalents vs competitors
How SLGL compares with its peers on the latest reported figures
- SLGL's Mar 2026 cash & equivalents of $10.14M is the 7th highest of the 10 companies compared; the peer median is $22.19M.
- Its year-over-year change of -40.0% is the 7th highest of 10, against a peer median of -23.8%.
- Cash & equivalents amounts to 17.3% of total assets for SLGL, versus a peer median of 30.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $94.06M | +345.0% | -33.6% | 41.7% | |
| Mar 2026 | $66.52M | -54.3% | -19.3% | 30.5% | |
| Mar 2026 | $50.72M | +42.8% | +99.1% | 95.2% | |
| Mar 2026 | $31.93M | -23.8% | -5.8% | 12.6% | |
| Mar 2026 | $22.19M | -75.9% | +10.5% | 11.0% | |
| Mar 2026 | $13.2M | -82.3% | +4.3% | 4.9% | |
| Mar 2026 | $10.14M | -40.0% | -3.9% | 17.3% | |
| Mar 2026 | $5.94M | -39.6% | -34.3% | 27.4% | |
| Sep 2025 | $4.22M | +327.5% | -16.7% | 90.9% | |
| Dec 2025 | $4.01M | +7.7% | -39.5% | 34.9% | |
| Peer median (excluding SLGL) | $22.19M | -23.8% | -16.7% | 30.5% | |
Competitors are the stored peer set for SLGL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 20.09M | 12.45M | 7.51M | 19.49M | 11.03M |
| Short-term Investments | 23.16M | 21.18M | 30.48M | 4.44M | 12.97M |
| Net Receivables | 13.07M | 7.92M | 377K | 3.6M | 1.97M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 2.79M | 3.77M | 1M |
| Total Current Assets | 57.11M | 43.06M | 41.17M | 31.3M | 26.97M |
| Property, Plant & Equipment (Net) | 2.55M | 1.54M | 2.16M | 1.63M | 1.17M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 8.7M | 1.29M | 1.28M | 2.32M | 1.32M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 830K | 749K | 681K | 608K | 455K |
| Total Non-current Assets | 12.08M | 3.57M | 4.12M | 4.55M | 2.95M |
| Total Assets | 69.19M | 46.63M | 45.29M | 35.85M | 29.92M |
| Account Payables | 766K | 251K | 154K | 1.27M | 735K |
| Short-term Debt | 0 | 0 | 0 | 0 | 495K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 4.49M |
| Total Current Liabilities | 11.69M | 3.33M | 4.52M | 5.29M | 6.17M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.09M | 1.03M | 915K | 833K | 439K |
| Total Non-current Liabilities | 1.9M | 1.09M | 2.12M | 1.71M | 935K |
| Total Liabilities | 13.6M | 4.42M | 6.64M | 7M | 7.11M |
| Common Stock | 638K | 638K | 774K | 774K | 774K |
| Retained Earnings | (178.14M) | (193.07M) | (220.3M) | (230.88M) | (237.01M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 55.59M | 42.21M | 38.64M | 28.85M | 22.81M |
| Total Debt | 1.59M | 772K | 1.65M | 1.31M | 991K |
| Net Debt | (18.49M) | (11.68M) | (5.86M) | (18.18M) | (10.04M) |
Sol-Gel Technologies Ltd.
NASDAQ:SLGL
Intrinsic Alpha fair value
Locked
Current Price
$53.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.